Biodegradation of PLA/GA polymers: increasing complexity

Biomaterials

Volumn 15, Issue 15, 1994, Pages 1209-1213

  Vert, Michel ^a   Mauduit, Jacques ^a   Li, Suming ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

Biodegradation; copolymers; poly(lactic acid)

Indexed keywords

ANTIBIOTICS; CARBOXYLIC ACIDS; COPOLYMERS; DIFFUSION; HYDROLYSIS; MOLECULAR STRUCTURE; POLYESTERS;

ALIPHATIC POLYESTERS; AUTOCATALYTIC EFFECT; GENTAMYCIN; GLYCOLIC ACIDS; POLYLACTIC ACID;

BIODEGRADATION;

GENTAMICIN; GLYCOLIC ACID; POLYESTER; POLYLACTIC ACID;

BIODEGRADATION; CONFERENCE PAPER; DIFFUSION; DRUG DELIVERY SYSTEM; MOLECULAR WEIGHT; PRIORITY JOURNAL;

EID: 0028564916     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(94)90271-2     Document Type: Article

References (28)

1. Bioresorbable polymers for temporary therapeutic applications
2. Non-microbial degradation of polyesters: mechanisms and modifications
3. Polymers for biodegradable medical devices. 1. The potential of polyesters as controlled macromolecule release systems
4. Factors influencing the release of peptides and proteins from biodegradable depot systems
5. In vitro evaluation of tailormade bioresorbable polymers and applications in bone surgery and drug delivery
6. Structure-property relationships in the case of the degradation of solid aliphatic poly(α-hydroxy acids) in aqueous media. 1: Poly(dl-lactic acid) or PLA50
7. Degradation of polymeric biomaterials with respect to temporary therapeutic applications: tricks and treats
8. Structure-property relationships in the case of the degradation of massive poly(αhydroxy acids) in aqueous media. 2: PLA37.5GA25 and PLA75GA25 copolymers
9. Structure-property relationships in the case of the degradation of massive poly(αhydroxy acids) in aqueous media. 3: Amorphous and semi-crystalline PLA100
10. In vivo degradation of massive poly(α-hydroxy acids): validation of in vitro findings
11. Stereoregular bioresorbable polyester for orthopaedic surgery
12. Vert M- Les stéréocopolymères et copolymères des acides lactiques et glycolique et la délivrance contrôlée de principes actifs
13. Sustained release of sulfamethiazole, 5-fluorouracil and doxorubicin from ethylcellulose/polylactic acid microcapsules
14. Erythromycin poly(lactic acid) microspheres for sustained delivery and reduced tissue irritation
15. Release of antibiotic from composites of hydroxyapatite and polyflactic acid)
16. Sustained release of sulphadiazine
17. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base or sulfate in poly(dl-lactic acid) oligomers
18. Bioresorbable plastic materials for bone surgery
19. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. II. The case of gentamycin sulfate in high molecular weight poly(dl-lactic acid) and poly(l-lactic acid)
20. Control of release rate of bleomycin from polylactic acid microspheres
21. Modification of the release rate of aclarubicin from polylactic acid microspheres by using additives
22. Controlled release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer
23. The effect of the addition of low molecular weight poly(d,l-lactide) on drug release from biodegradable poly(d,l-lactide) drug delivery systems
24. Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin sulfate in films prepared from high and low molecular weight poly(dl-lactic acid)s
25. Poly(lactic acid). 1. Stereosequence distribution in the polymerization of racemic dilactide
26. 1H n.m.r.
27. Stereocomplex formation between enantiomeric poly(lactic acid)s. 5. Calorimetric and morphological studies of the stereocomplex formed in acetonitrile
28. Crystalline oligomeric stereocomplex as intermediate compound in racemic poly(dl-lactic acid) degradation